(Q35164536)

English

Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Clostridium difficile

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Kathleen M Mullane

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Mark A Miller

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Karl Weiss

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Arnold Lentnek

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Yoav Golan

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Pamela S Sears

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Youe-Kong Shue

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Thomas J Louie

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sherwood L Gorbach

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

0 references

publication date

1 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

440-447

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

Effects of treatment with antimicrobial agents on the human colonic microflora

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

Antimicrobial-associated risk factors for Clostridium difficile infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

Nitazoxanide for the treatment of Clostridium difficile colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of an initial episode of Clostridium difficile-associated diarrhoea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

Clinical practice. Antibiotic-associated diarrhea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

Risk of diarrhoea, Clostridium difficile and cefotaxime in the elderly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

Diagnosis and treatment of Clostridium difficile colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

Clostridium difficile colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

Effects of antibiotics and other drugs on toxin production in Clostridium difficile in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

Clindamycin-associated colitis. Review of the clinical spectrum of 47 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

13 July 2018

A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

27 September 2018

Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

27 September 2018

Prevalence of Clostridium difficile colonization at admission to rehabilitation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

27 September 2018

Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3156139

27 September 2018

Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea

1 reference

https://pubmed.ncbi.nlm.nih.gov/21844027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral bacitracin vs vancomycin therapy for Clostridium difficile-induced diarrhea. A randomized double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21844027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea

1 reference

https://pubmed.ncbi.nlm.nih.gov/21844027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clindamycin-associated colitis. A prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21844027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clostridium difficile-Associated Diarrhea and Colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21844027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21844027

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/CID/CIR404

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35164536&oldid=1527080017"